| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Studies |
Department of Clinical Nutrition (R.S., M.U.) and Department of Medicine (S.H., M.L.), University of Kuopio, 70211 Kuopio; Eating Disorder Unit (A.R.), University Hospital of Helsinki, 00270,Helsinki, Finland
Address correspondence and requests for reprints to: Raisa Sipiläinen, M.Sc., Department of Clinical Nutrition, University of Kuopio, P.O. Box 1627, 70211 Kuopio, Finland. E-mail: raisa.sipilainen{at}uku.fi
Fatty acid binding protein 2 gene (FABP2) has been proposed to be an
important candidate gene for insulin resistance; therefore, it also
could be a promising candidate gene for obesity. We screened the whole
coding region of the FABP2 gene in 40 obese nondiabetic Finnish
subjects. Furthermore, we investigated the effects of the codon 54
polymorphism of this gene (Ala
Thr) on insulin levels and basal
metabolic rate in 170 obese subjects. The frequencies of the variants
found in exon 4 (GTA
GTG) and 3'-noncoding region (GCGCA
GCACA), as well as the allele frequencies for the variable lengths of
the ATT repeat sequence in intron 2 did not differ between the obese
subjects and nonobese controls. The frequency of threonine-encoding
allele in codon 54 of the FABP2 gene did not differ between obese and
control subjects (28 vs. 29%, respectively). In the
obese group there were no differences in gender distribution, age,
weight, body mass index, lean body mass, percentage of body fat, waist
circumference, and waist-to-hip ratio among the individuals homozygous
for Ala54, heterozygous for Thr54, and
homozygous for Thr54-encoding alleles. Similarly, fasting
serum insulin, glucose, lipids and lipoprotein concentrations, basal
metabolic rate (adjusted for lean body mass and age), respiratory
quotient, and rates of glucose and lipid oxidation did not differ among
the groups. We conclude that obesity is not associated with specific
variants in the FABP2 gene. Furthermore, the codon 54 Ala to Thr
polymorphism of this gene does not influence insulin levels or basal
metabolic rate in obese Finns.
This article has been cited by other articles:
![]() |
S. Morcillo, G. Rojo-Martinez, F. Cardona, M. de la Cruz Almaraz, M. de la Soledad Ruiz de Adana, I. Esteva, I. Cardona, and F. Soriguer Effect of the interaction between the fatty acid binding protein 2 gene Ala54Thr polymorphism and dietary fatty acids on peripheral insulin sensitivity: a cross-sectional study Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1232 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Stan, M. Lambert, E. Delvin, G. Paradis, J. O'Loughlin, J. A. Hanley, and E. Levy Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth J. Lipid Res., February 1, 2005; 46(2): 320 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lara-Castro, G. R. Hunter, J. C. Lovejoy, B. A. Gower, and J. R. Fernandez Association of the Intestinal Fatty Acid-Binding Protein Ala54Thr Polymorphism and Abdominal Adipose Tissue in African-American and Caucasian Women J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1196 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Dworatzek, R. A Hegele, and T. M. Wolever Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested Am. J. Clinical Nutrition, June 1, 2004; 79(6): 1110 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Weiss, M. D. Brown, A. R. Shuldiner, and J. M. Hagberg Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects Physiol Genomics, September 3, 2002; 10(3): 145 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Levy, D. Menard, E. Delvin, S. Stan, G. Mitchell, M. Lambert, E. Ziv, J. C. Feoli-Fonseca, and E. Seidman The Polymorphism at Codon 54 of the FABP2 Gene Increases Fat Absorption in Human Intestinal Explants J. Biol. Chem., October 19, 2001; 276(43): 39679 - 39684. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Galluzzi, L. A. Cupples, J. B. Meigs, P. W.F. Wilson, E. J. Schaefer, and J. M. Ordovas Association of the Ala54-thr Polymorphism in the Intestinal Fatty Acid-Binding Protein With 2-h Postchallenge Insulin Levels in the Framingham Offspring Study Diabetes Care, July 1, 2001; 24(7): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Pratley, L. Baier, D. A. Pan, A. D. Salbe, L. Storlien, E. Ravussin, and C. Bogardus Effects of an Ala54Thr polymorphism in the intestinal fatty acid-binding protein on responses to dietary fat in humans J. Lipid Res., December 1, 2000; 41(12): 2002 - 2008. [Abstract] [Full Text] |
||||
![]() |
A. Georgopoulos, O. Aras, and M. Y. Tsai Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 Diabetes J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3155 - 3160. [Abstract] [Full Text] |
||||
![]() |
M. Carlsson, M. Orho-Melander, J. Hedenbro, P. Almgren, and L. C. Groop The T 54 Allele of the Intestinal Fatty Acid-Binding Protein 2 Is Associated with a Parental History of Stroke J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2801 - 2804. [Abstract] [Full Text] |
||||
![]() |
A. Meirhaeghe, G. Martin, M. Nemoto, S. Deeb, D. Cottel, J. Auwerx, P. Amouyel, and N. Helbecque Intronic Polymorphism in the Fatty Acid Transport Protein 1 Gene Is Associated With Increased Plasma Triglyceride Levels in a French Population Arterioscler. Thromb. Vasc. Biol., May 1, 2000; 20(5): 1330 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Agren, R. Valve, H. Vidgren, M. Laakso, and M. Uusitupa Postprandial Lipemic Response Is Modified by the Polymorphism at Codon 54 of the Fatty Acid–Binding Protein 2 Gene Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1606 - 1610. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |